Introduction
Collagen type I is excessively deposited in the extracellular matrix protein in hepatic fibrosis (1, 2) , which in turn contributes to the morbidity and mortality of patients with chronic liver diseases (3) . Hepatic stellate cells play a key role in the pathogenesis of hepatic fibrosis (4, 5) . Although we (6) and others (7, 8) reported that quiescent stellate cells produce little collagen type I, proliferating, activated (myofibroblastic) stellate cells display a high level of collagen ␣ 1 (I) gene expression. In addition, the degree of fibrogenesis in liver diseases is most likely affected by the increased population of stellate cells, which results from their proliferation (9) .
Therefore, stellate cell proliferation is a critical step in hepatic fibrogenesis. Studies with primary cultures of adult rat stellate cells have provided evidence that cell type-specific mechanisms modulate their proliferation (10) (11) (12) . For example, the induction of stellate cell proliferation by TGF ␣ or collagen type I matrix is mediated by oxidative stress through c-myb and probably NFkB (11) . Conversely, endothelin-1 inhibits the growth of stellate cells (12) . However, little is known about the signal transduction pathways and the nuclear factors involved in either the normal, quiescent or the activated, proliferating phenotype of hepatic stellate cells. Because stimulation of the cyclic adenosine 3 Ј ,5 Ј monophosphate (cAMP)-dependent protein kinase (PKA) 1 inhibits proliferation of some tumoral cell lines (13) (14) (15) , we analyzed the potential role of this signal transduction pathway on stellate cell proliferation.
In this study, we found that stimulation of the cAMP/PKA signal transduction pathway (16) , or its parallel pathway Ca 2 ϩ / calmodulin kinase-II (CAMK-II) (17, 18), inhibits proliferation of activated stellate cells. Moreover, our results suggest that activation of either PKA or CAMK-II induces phosphorylation of CREB on Ser 133, which is an important modulator of the stellate cell cycle.
Methods
Cell cultures. Stellate cells were prepared from male Sprague-Dawley rats (400-500 g) by in situ perfusion and single-step density Nycodenz gradient (Accurate Chemical & Scientific Corp., Westbury, NY), as described previously (6, 19) . Cells were plated on collagen type I, EHS matrix (Matrigel), or plastic (according to the experimental design) tissue culture dishes, with the initial seeding of fatstoring cells at a density of 2 ϫ 10 TGF ␤ , fibroblast growth factor, and tissue plasminogen activator. Medium was changed every 48 h for all conditions. Stellate cells were identified by their typical autofluorescence at 328 nm excitation wavelength, staining of lipid droplets by oil red, and immunohistochemistry with a monoclonal antibody against desmin (20) . Greater than 95% of the cells were stellate cells. Freshly isolated stellate cells were transfected with the mammalian vectors expressing the protein of interest using lipofectin (GIBCO BRL, Gaithersburg, MD) as described by the manufacturer. To increase the transfectability of activated cells, a transfection-enhancing reagent (Life Technologies Inc., Gaithersburg, MD) was added in conjunction with lipofectamine as recommended by the manufacturer. The total amount of transfected DNA was 2.5 g. The transfection efficiency was 44 Ϯ 10% for day 0 quiescent cells and 28 Ϯ 8% for activated cells growing on a collagen type I matrix. Cells were fixed at 48 or 120 h after transfection for passage 1 and passage 0, respectively. In some experiments, cells were labeled with 2 Ci [ 3 H]thymidine incorporation into DNA was determined as described (21) .
Nuclear extract preparation. Nuclei were prepared by a modification of the procedure described previously (21) (22) (23) . Cells were homogenized in 1 ml of 100 mM KCl, 10 mM Tris, pH 7.6, 1 mM EDTA, 0.5% NP-40, 10 mM NaF, and 10 mM Na pyrophosphate with a glass Dounce homogenizer with a loose fitting pestle. The homogenized cells were placed above a cushion consisting of 2 M sucrose. The nuclei were precipitated by a 4,000 g centrifugation at 4 Њ C for 30 min and frozen at Ϫ 70 Њ C.
Immunohistochemistry. Cells were fixed with acetone/methanol (50:50) at Ϫ 20 Њ C for 20 min and immunostained as described previously (20, 21) . Antibodies directed against ␤ -galactosidase, CREB, CREB-PSer133, or proliferating cell nuclear antigen (PCNA) were obtained from 5 Prime-3 Prime, Inc. (Boulder, CO), New England Biolabs Inc. (Beverly, MA), Upstate Biotechnology, Inc. (Lake Placid, NY), and Novocastra (Burlingame, CA). Fluorescent labels were visualized using a dual channel Zeiss microscope as described previously (21) . Cytochromes used were FITC and Texas red (Vector Labs, Inc., Burlingame, CA). The number of PCNA( ϩ ) cells was expressed as a percentage of total transfected cells ( ␤ -galactosidase [ ϩ ]). At least 200 cells were analyzed per each experimental point, and a minimum of two observers analyzed each immunohistochemical experiment as described previously (21) . Negative control samples were processed in parallel under the same conditions, but with omission of the first antibody. Detection of CREB and CREB-PSer133 in nuclear extracts from rat stellate cells in primary culture or freshly isolated from rat livers was performed by Western blot following the chemiluminescence protocol (DuPont, Wilmington, DE), using antibodies against CREB (Santa Cruz Biotechnologies, Santa Cruz, CA) or CREB-PSer133 (Upstate Biotechnology, Inc.) as described (22, 23) .
Statistical analysis. Results were expressed as mean of at least three independent experiments. Both the ANOVA and Bonferroni tests were used for analysis of variance, with a P value of Ͻ 0.05 as significant.
Results
First, we examined the role of cAMP on the proliferation of activated primary rat stellate cells. Inhibition of stellate cell proliferation was attempted in passage 0 cells activated on collagen type I for 6 d or in passage 1 cells activated on plastic for 11 d (7, 8, 11) . These cells exhibited a high entry into S-phase ( Ͼ 80%) in agreement with previous studies (11) . Cell proliferation was determined by incorporation of [ 3 H]thymidine into DNA, which occurs in S-phase, as described previously (21) . As shown in Fig. 1 , proliferation of stellate cells whether activated by collagen type I or plastic was blocked by elevation of cAMP with 8Br-cAMP (100 M), a cAMP isomer resistant to hydrolysis, and/or isomethylbutyl xanthine (500 M), a phosphodiesterase inhibitor.
Because intracellular Ca 2 ϩ fluxes modulate many cellular functions in parallel to cAMP (16) (17) (18) , we analyzed whether A-23187 (1 M), an inducer of Ca 2 ϩ fluxes (24), had similar effects to cAMP on stellate cell proliferation. We found that treatment of activated stellate cells with A-23187 also inhibited cell entry into S-phase ( Fig. 1) .
Many of the cellular effects resulting from the activation of cAMP/PKA pathway are mediated by the phosphorylation of CREB on Ser 133 (25, 26) . Therefore, we assessed the role of CREB-PSer133 on stellate cell cycle. Nuclei were obtained from quiescent and activated stellate cells through a sucrose gradient in the presence of protease and phosphatase inhibitors as described (23, 27) . Equal amounts of nuclear protein from quiescent and activated stellate cells were analyzed by SDS-PAGE and visualized by Coomassie blue staining (Fig.  2) . Using specific antibodies in a protein immunoblot, we detected CREB as 43-kD monomers in nuclear extracts from quiescent cells. The amount of CREB was decreased in nuclear extracts from proliferating, activated stellate cells (Fig.  2) . In nuclear extracts from quiescent cells, CREB was phosphorylated on Ser 133 (Fig. 2) . In addition to recognizing CREB in protein immunoblots, anti-CREB-PSer133 detected small quantities of two other proteins after longer exposures. These are most likely members of the CREB-ATF family, ATF1 or CREB ␤ (38 kD) and CREM (30 kD) , that have phosphoacceptor sequences similar to that of CREB-PSer133 (28) . The phosphorylation of ATF-1 and CREM can be induced by cAMP and Ca 2 ϩ (18). Nuclear extracts from activated stellate cells contained negligible amounts of CREBPSer133 (Fig. 2) , suggesting a role for CREB/CREB-PSer133 on the stellate cell cycle. As expected, PCNA, an index of S-phase (29) , was present in nuclear extracts from activated cells, but not in nuclear extract from quiescent cells (Fig. 2) , indicating that the decrease in CREB/CREB-PSer133 in activated cells was not due to a spurious effect of nuclear extraction. Moreover, the results shown in Fig. 2 are representative of four independent nuclear extracts from quiescent and activated stellate cells.
In subsequent experiments, we analyzed whether phosphorylation of CREB on Ser 133 is critical for the inhibition of stellate cell proliferation. Activated cells were transfected with vectors expressing the protein of interest (21, 22) , and cultured on collagen type I to maintain their activated phenotype (11) . Most of the cells expressing the control ␤ -galactosidase alone entered S-phase ( Ͼ 80%), as indicated by the expression of PCNA (cyclin; polymerase ␦ accessory protein) (29) (Fig. 3 A ) . Cells underwent organic fixation which permits the detection of PCNA in the nucleus during S-phase (30) . Of interest, coexpression of CREB and a constitutively active PKA (25, 31) together with ␤ -galactosidase inhibited the proliferation of these activated cells. In contrast, expression of ␤ -galactosidase with CREB alone, PKA alone, or CREB-Ala 133 (which lacks the Ser 133 phosphoacceptor [25, 26] ) with PKA did not affect stellate cell proliferation (Fig. 3 A ) . These results suggest that PKA-induced phosphorylation of CREB on Ser 133 is necessary for the inhibition of stellate cell proliferation, since unlike wt CREB, CREB-Ala 133 was refractory to the effects of PKA on cell entry into S-phase. Neither the expression of CREB nor the expression of a constitutively active PKA was sufficient to prevent cells to enter S-phase. In Fig. 4 , representative examples of the dissociation between CREB/PKA expression and stellate cell cycle S-phase, assessed by PCNA (bright green-yellow), are shown. The transfected cells were identified by the expression of cytoplasmic ␤ -galactosidase (in red). Nuclear expression of PCNA was high in control activated cells but it was markedly inhibited in stellate cells expressing both CREB and PKA. However, the nuclear expression of PCNA in cells transfected with CREB-Ala133 and PKA or CREB and an inactive PKA mutant (25) was comparable with control cells (Fig. 4) . Because CAMK-II is activated by Ca 2 ϩ fluxes and under some experimental conditions is capable of inducing phosphorylation of CREB on Ser 133 (17), we also analyzed the effects of this pathway on the stellate cell cycle. Coexpression of CREB and a constitutively active CAMK-II (32) inhibited proliferation of activated cells (Fig.  3 B ) . In contrast, expression of CAMK-II alone, CREB-Ala133 with CAMK-II, or CREB with an inactive CAMK-II mutant (32) To analyze further the role of CREB-PSer133 on the stellate cell cycle, we performed immunofluorescence for CREBPSer133 in activated cells using specific antibodies that do not cross-react with nonphosphorylated CREB at Ser 133 (28) . As depicted in Fig. 5 , when proliferating, activated stellate cells were treated with 8Br-cAMP, IBMX, forskolin (not shown), or A-23187 they expressed nuclear CREB-PSer133, whereas untreated activated stellate cells did not.
Next, we studied whether CREB/CREB-PSer133 contribute to the inhibition of the cell cycle in quiescent stellate cells. In these cells, expression of the trans -dominant negative CREB-Ala133 induced a greater than fivefold entry into S-phase of quiescent stellate cells, compared with control cells expressing either ␤ -galactosidase alone or with wt CREB (Fig. 6) . The mutant CREB-Ala133 lacks the Ser 133 phosphoacceptor but competes with wt CREB for cognate DNA binding sites, and behaves as an antagonist (25) . Thus, expression of a CREB mutant that cannot be phosphorylated on Ser 133 is sufficient to stimulate stellate cell proliferation.
Because oxidative stress and malondialdehyde (MDA), a product of lipid peroxidation, are strong inducers of stellate cell proliferation (11), we tested whether these effects of MDA could be neutralized by CREB-PSer133. We found that day 6 stellate cells cultured on a collagen type I matrix and expressing wt CREB and active PKA proliferated as much as control cells when treated with MDA (Fig. 7) . Conversely, butylated hydroxytoluene, an antioxidant that prevents the entry of stellate cells into S-phase induced by collagen type I matrix or TGF ␣ (11), also blocked the proliferation of stellate cells cultured on EHS matrix, when stimulated by the expression of the mutant CREB-Ala133. These results suggest that oxidative stress affects the cascade leading to stellate cell proliferation at a site distal to the effects of CREB-PSer133.
Discussion
Although overproduction of collagen type I by activated hepatic stellate cells is a critical step in the development of liver cirrhosis (4, 5, 7, 8) , the mechanisms responsible for the proliferation and activation of hepatic stellate cells remain unclear (3) . In this study, we have characterized some of the signal transduction pathways that are involved in the modulation of the stellate cell cycle. Induction of either the cAMP/PKA or Ca 2 ϩ /CAMK-II pathway (16) (17) (18) inhibits proliferation of acti- Figure 4 . CREB phosphorylation on Ser133 is associated with arrest of the hepatic stellate cell cycle. Activated stellate cells were transfected as described in Fig. 3 with vectors expressing CREB alone (A); CREB ϩ PKA (B); CREB ϩ PKA inactive mutant (pCaK72M) (C); CREB ϩ CAMK-II (D); and CREB ϩ CAMK-II mutant (E). Cells were fixed 48 h after transfection and dual immunofluorescence was performed for ␤-galactosidase (red) and PCNA (bright green-yellow). Cells expressing CREB ϩ PKA or CREB ϩ CAMK-II did not enter S-phase. vated stellate cells. Moreover, we have identified a molecular mechanism leading to entry of stellate cells into S-phase or arrest before the G 1 /S boundary.
Our results suggest an important role of CREB Ser133 phosphorylation on the stellate cell cycle. The stellate cell cycle arrest induced by CREB-PSer133 results from the interaction between wt CREB and either active PKA or active CAMK-II, as strongly suggested by the ineffectiveness of: ( a ) CREB-Ala133 in the presence of constitutively active PKA or CAMK-II; ( b ) active PKA or active CAMK-II; and ( c ) wt CREB in the presence of mutant PKA or mutant CAMK-II. Also, we determined that quiescent cells can be induced to enter S-phase when they expressed the trans -dominant negative CREB-Ala133. In agreement with these results, we found that stellate cell cycle can be arrested by elevation of cAMP with 8Br-cAMP or IBMX or by inducing Ca 2 ϩ fluxes with the Ca 2 ϩ ionophore A-23187. In contrast, quiescent stellate cell entry into S-phase is markedly induced by interfering with the activity of CREB/ CREB-PSer133, with the trans-dominant negative CREBAla133. As for many other cellular functions (33) , intracellular Ca 2ϩ as well as cAMP seems to modulate the stellate cell cycle. In addition, activation of the cAMP/PKA pathway by M-phasepromoting factor is required for the transition from mitosis to interphase (34) . Interestingly, either increased cAMP (35) or Ca 2ϩ mobilization (24) inhibits collagen production by fibroblasts. A similar inhibitory effect of cAMP or Ca 2ϩ fluxes on collagen production by stellate cells is expected, since quiescent stellate cells have a low expression of collagen type I gene compared with their activated, proliferating counterparts (4, 5, 19) .
Because oxidative stress and reactive aldehydes induce the proliferation of quiescent stellate cells (11) , and stimulate collagen transcription (36, 37) , and antioxidants suppress the proliferation of activated stellate cells (11) as well as collagen gene expression (38), we analyzed whether oxidative stress affects the cell cycle at a site proximal or distal to the effects of CREB-PSer133. The antioxidant butylated hydroxytoluene (38) prevented the stimulation of quiescent stellate cell entry into S-phase by the mutant CREB-Ala133 (an antagonist of CREB). Moreover, exposure of proliferating, activated stellate cells to MDA, an aldehyde product of lipid peroxidation (37) , prevented the cell cycle arrest by wt CREB and active PKA. Collectively, these results suggest that oxidative stress modulates the stellate cell cycle cascade at a site distal to the effects of CREB-PSer133. In this context, we have also demonstrated that quiescent stellate cells express nuclear CREB and CREB-PSer133, whereas nuclear expression of CREBPSer133 in activated stellate cells is stimulated by the elevation of cAMP or by Ca 2ϩ mobilization. Given the results of this study, we expect that stellate cell proliferation will be facilitated by a targeted disruption of the CREB gene (39) . In contrast to CREB-PSer133, CREB phosphorylation on Ser 119 seems to be required for T cell activation and cell-cycle progression (40) .
Although little is known about the mechanisms by which CREB/CREB-PSer133 affects the cell cycle, CREB/CREBPSer133 function can be modulated by CREB binding protein (CBP) (41, 42) . Recent studies indicate that CBP binding affinity can be regulated by site-specific phosphorylations mediated by PKA (16) and p90 rsk (43) . The precise molecular interaction of CREB/CREB-PSer133 with CBP and other transcription factors is poorly understood. However, Kamei et al. (44) have proposed that CBP could act as a key integrator of cellular functions by selectively interacting with different transcription factors. For example, CBP is known to bind preferentially to the oncoproteins c-myb and c-jun, or to the cell-cycle arresting factors RARs (retinoic acid receptors) and CREB, according to the biological conditions (41) (42) (43) (44) (45) . Taken together, these results suggest the possibility that CREB/CREB-PSer133 could compete with c-myb for interaction with CBP (45), thereby af- fecting the role of c-myb in the activation of stellate cells (11) . Likewise, the important role of retinoids on quiescent stellate cell phenotype (7, 9) could be related to their activation of RARs and the potential facilitation of the interaction between CBP and CREB-PSer133 (41, 42) . Alternatively or in addition, the role of cAMP may reflect its modulation of the retinoic acid-dependent RAR's transcription, given the presence of CREB binding sites on the RAR-␤ 2 promoter (46) .
In this study, we have identified a novel function of CREBPSer133 as a regulator of the cell cycle in highly differentiated cells. A similar inhibitory role on the cell cycle has also been found for other transcription factors such as MyoD, C/EBP␣, and LAP (21, 47, 48) , known to induce differentiated phenotypes in skeletal muscle, adipocytes, and hepatocytes (49) . However, in poorly differentiated cell lines, such as erythroleukemia K562 and pheochromocytoma PC-12, growth factors activate the RSK2 kinase which induces phosphorylation of CREB on Ser 133 (50), indicating that under certain growth conditions, CREB-PSer133 is not sufficient to block cell cycle progression, as suggested by our results with oxidative stress (Fig. 7) . In summary, our study provides insights into the molecular mechanisms modulating hepatic stellate cell cycle, as well as a rationale for potential therapeutic approaches for hepatic fibrosis.
